AT7867 Inhibits Human Colorectal Cancer Cells via AKT-Dependent and AKT-Independent Mechanisms

AKT is often hyper-activated in human colorectal cancers (CRC). This current study evaluated the potential anti-CRC activity by AT7867, a novel AKT and p70S6K1 (S6K1) dual inhibitor. We showed that AT7867 inhibited survival and proliferation of established (HT-29, HCT116 and DLD-1 lines) and primary...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Shihu, Deng, Zhengming, Yao, Chen, Huang, Ping, Zhang, Yi, Cao, Shibing, Li, Xiangcheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5231330/
https://www.ncbi.nlm.nih.gov/pubmed/28081222
http://dx.doi.org/10.1371/journal.pone.0169585

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5231330/
https://www.ncbi.nlm.nih.gov/pubmed/28081222
http://dx.doi.org/10.1371/journal.pone.0169585

Ejemplares similares